Lixi Ding (利喜定)利喜定
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
批准文号:NMPA approval number: 国药准字H20000463
生产企业Manufacturer
- 西安利君制药有限责任公司Chinese legal name: 西安利君制药有限责任公司
主要成分Active Ingredients
- 乌拉地尔Wula Dier
药物知识说明
国药准字H20000463是一种在国家药监局注册认定的药品。该药品含有乌拉地尔-1227c239等成分。
该药品关联的活性成分包括：乌拉地尔Wula Dier。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：西安利君制药有限责任公司Chinese legal name: 西安利君制药有限责任公司。
您可以探索含有相同成分的其他药品：乌拉地尔-1227c239成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 利喜定) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 乌拉地尔Wula Dier.
Manufacturers recorded for this product: 西安利君制药有限责任公司Chinese legal name: 西安利君制药有限责任公司.
Explore other medicines containing the same ingredient: 乌拉地尔 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 利喜定Recorded Chinese name: 利喜定
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 30mg*10片*2板30 mg × 10 tablets × 2 blister boards
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 西安利君制药有限责任公司Chinese legal name: 西安利君制药有限责任公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20000463
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20000463
Manufacturer
Chinese legal name: 西安利君制药有限责任公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20000463
生产企业
西安利君制药有限责任公司(国产)
适应症
本品主要用于原发性高血压，肾性高血压，嗜铬细胞瘤引起的高血压。
用法用量
口服，成年人服用乌拉地尔通常从每天1片开始，当效果不明显时，可在1～2周的时间内逐渐增加剂量至每天2片或4片，分两次口服。或遵医嘱。
不良反应
1.可见头痛、头晕、恶心、呕吐、疲劳、心悸、心律失常、瘙痒和失眠等，若超量用药或用药初期剂量增加过快时，可引起头晕、直立性低血压，虚脱及疲劳等，必要时应给予对症治疗。
2.偶有食欲不振、胃部不适、腹泻、浮肿?GOT?GPT?GPK升高等。
禁忌
1.对本品过敏者禁用。
2.孕妇及哺乳期妇女禁用。
注意事项
1.驾车或操作机器者应慎用。
2.应避免与酒精类饮料合用。
3.高龄及肝功能障碍患者应慎用。
4.本品与其它降压药合用，可增强降压作用.同时服用西咪替丁，会提高本品的血药浓度。
5.因本品为缓释制剂，因此不宜咀嚼或咬碎服用，以防止一过性血药浓度上升。
贮藏
密闭，在25℃以下保存。
规格
30mg*10片*2板
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.